OTHER ASSETS AND OTHER LIABILITIES AND DEFERRED INCOME

Other assets and other liabilities and deferred income consist of various balance sheet items that are combined for financial statement presentation due to their respective materiality compared with other individual asset and liability items.

Other assets were as follows (in millions):



	December 31, 2017		March 31, 2018
Accrued interest and other non-finance receivables	$	1,117	$	1,059
Collateral held for resale, at net realizable value, and other inventory	780		755
Prepaid reinsurance premiums and other reinsurance recoverables	611		624
Deferred charges – income taxes	247		239
Property and equipment, net of accumulated depreciation (a)	177		181
Restricted cash (b)	124		148
Deferred charges	127		126
Investment in non-consolidated affiliates	107		126
Other	39		43
Total other assets	$	3,329	$	3,301

__________


(a)	Accumulated depreciation was $354 million and $363 million at December 31, 2017 and March 31, 2018, respectively.


(b)	Restricted cash primarily includes cash held to meet certain local governmental and regulatory reserve requirements and cash held under the terms of certain contractual agreements. Restricted cash does not include required minimum balances or cash securing debt issued through securitization transactions.

Other liabilities and deferred income were as follows (in millions):



	December 31, 2017		March 31, 2018
Unearned insurance premiums and fees	$	723	$	736
Interest payable	722		608
Income tax and related interest (a)	301		297
Deferred revenue	148		150
Payroll and employee benefits	68		45
Other	310		318
Total other liabilities and deferred income	$	2,272	$	2,154

__________

(a) Includes tax and interest payable to affiliated companies of $99 million and $103 million at December 31, 2017 and March 31, 2018, respectively.

We have investments in entities for which we do not have the ability to exercise significant influence and fair values are not readily available. We have elected to record these investments at cost (less impairment, if any), adjusted for changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. We report the carrying value of these investments in Other assets in our consolidated balance sheet. These investments were $7 million and $9 million at December 31, 2017 and March 31, 2018, respectively. There were no material adjustments to the fair values of these investments during the period ending March 31, 2018.

Deferred revenue balances presented above include amounts from contracts with customers primarily related to admission fee revenue on group financing products available in Argentina and were $124 million at both December 31, 2017, and March 31, 2018.

Admission fee revenue on group financing products is generally recognized evenly over the term of the agreement, which is up to 84 months. Increases in the admission fee deferred revenue balance are the result of payments due during the current period in advance of satisfying our performance under the contract and decreases are a result of revenue recognized during the current period that was previously deferred.